Medikea Raises $1.2M Pre-Seed to Expand Hybrid Healthcare Model in Tanzania

Medikea, a Tanzanian hybrid healthcare provider, has raised a $1.2 million pre-seed round. The round is dated 26 October 2026. Investors participating include Impacc, Hustle Fund, Catalyst Fund, Madica, develoPPP Ventures, O'Shaughnessy Ventures, Baobab Network, and Madiro. A lead investor was not specified in the available data.

What Medikea Does

Medikea combines a 24/7 telemedicine app with its own network of outpatient clinics, pharmacies, and diagnostic labs. The goal is to make primary care affordable and accessible.

Founded in 2020 by physician Dr Elvis Silayo and headquartered in Dar es Salaam, the company serves patients across several channels:

• Online consultations through its telemedicine app, available around the clock.
• In-clinic visits at its own outpatient facilities.
• Medicine delivery through its pharmacy network.
• At-home lab testing supported by its diagnostic labs.

The integrated model is designed to deliver care faster and at a lower cost than public hospitals and traditional private providers. By owning clinics, pharmacies, and labs alongside the digital front door, Medikea controls more of the patient journey than a standalone telehealth app would.

Why the Hybrid Model Stands Out

Pure telemedicine has well-known limits in emerging markets: a consultation is only useful if the patient can then access diagnostics, medicines, and follow-up care. Medikea's structure addresses that gap by pairing the app with physical infrastructure.

That combination also creates multiple revenue touchpoints per patient — consultation, lab testing, and medicine delivery — rather than relying on a single transaction. For a primary care business targeting affordability, owning the downstream assets is a way to control cost and capture margin that would otherwise go to third parties.

Investor Base

The pre-seed round brings together a mix of impact-oriented funds, early-stage venture investors, and development-linked programmes:

• Impacc
• Hustle Fund
• Catalyst Fund
• Madica
• develoPPP Ventures
• O'Shaughnessy Ventures
• Baobab Network
• Madiro

The breadth of the syndicate — spanning impact capital, African early-stage specialists, and a development-focused venture programme — reflects the dual commercial and public-health character of the business.

Acquisition Angle

Healthcare delivery in East Africa is a market where scale and infrastructure ownership matter. Medikea's combination of a digital platform and owned clinical assets makes it a potentially interesting target for several categories of acquirer:

• Regional healthcare groups looking to add a digital front door and telemedicine capability to existing clinic networks.
• Pharmacy and diagnostics operators seeking to extend into primary care consultations and at-home testing.
• Health insurers and payers interested in controlling cost of care through owned primary care delivery.
• Digital health platforms expanding into African markets that need physical infrastructure to complement an app-based model.

The pre-seed stage means the company is still early. The round's role is to fund the build-out of the model; the customer volumes and unit economics that acquirers would evaluate will develop from here.

What Remains Unclear

The funding amount is $1.2 million, but a lead investor was not identified in the available data, and no source URL was provided. Details on how proceeds will be allocated were not disclosed.

Summary

Medikea has raised $1.2 million in pre-seed funding dated 26 October 2026, with participation from Impacc, Hustle Fund, Catalyst Fund, Madica, develoPPP Ventures, O'Shaughnessy Ventures, Baobab Network, and Madiro. The Dar es Salaam-based company, founded in 2020 by Dr Elvis Silayo, operates a 24/7 telemedicine app alongside its own outpatient clinics, pharmacies, and diagnostic labs, offering online consultations, in-clinic visits, medicine delivery, and at-home lab testing with the aim of delivering care faster and at lower cost than public hospitals and traditional private providers.